Maternal opioid use disorder and hepatitis C infection in pregnancy reshape the peripheral immune landscape at term
This study was supported by grants from the National Institutes of Health: 1R01DA059152-01 (IM and JO), 7R01AI145910-05S1(IM), TL1TR001997 (HT) and pilot funding from the University of Kentucky, including the Clinical and Translational Science Substance Use Disorder pilot grant 3210003238 (IM and JO). This research was indirectly supported by the Kentucky Opioid Response Effort (KORE) via Substance Abuse and Mental Health Services Administration (SAMHSA) Grants, H79TI081704, H79TI083283, as well as the data management system that is hosted by UK with grant support from NIH CTSA UL1TR001998. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the University of Kentucky.
Authors
- Heather True (ORCID: https://orcid.org/0000-0002-6408-1490)
- Brianna M. Doratt (ORCID: https://orcid.org/0000-0002-8107-724X)
- Delphine C. Malherbe (ORCID: https://orcid.org/0000-0001-6416-6227)
- Cynthia Cockerham
- John O'Brien
- Ilhem Messaoudi
- Zachary M. Reynolds
- Sheridan B. Wagner
Institutions
- University of Kentucky (US)
Publication Details
- Journal
- EBioMedicine
- Published
- 2026-03-17
- DOI
- https://doi.org/10.1016/j.ebiom.2026.106214
- Primary Topic
- Pregnancy and Medication Impact
- Type
- article
- Field-Weighted Citation Impact
- 0.00